656
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial

, , , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 1345-1352 | Received 05 Jan 2023, Accepted 11 Jul 2023, Published online: 16 Aug 2023

References

  • Friedlander ML, Markman M. Chemotherapy. In: Berek JS, Hecker NF, editors. Berek & Hacker’s Gynecologic Oncology. 16th ed. Philadelphia: Wolters Kluwer; 2020:58–84.
  • Sommariva S, Pongiglione B, Tarricone R. Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review. Crit Rev Oncol Hematol. 2016;99:13–36. doi:10.1016/j.critrevonc.2015.12.001
  • Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 2021;26:100278. doi:10.1016/j.ctarc.2020.100278
  • National Comprehensive Cancer Network. Antiemesis (Version 2.2022). Available from: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed October 05, 2022.
  • May MB, Glode AE. Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics. Cancer Manag Res. 2016;8:49–55. doi:10.2147/CMAR.S81425
  • Tafelski S, Häuser W, Schäfer M. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews. Schmerz. 2016;30(1):14–24. doi:10.1007/s00482-015-0092-3
  • Todaro B. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. J Natl Compr Canc Netw. 2012;10(4):487–492. doi:10.6004/jnccn.2012.0048
  • Darmani NA. Mechanisms of broad-spectrum antiemetic efficacy of cannabinoids against chemotherapy-induced acute and delayed vomiting. Pharmaceuticals. 2010;3(9):2930–2955. doi:10.3390/ph3092930
  • Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol. 2011;163(7):1411–1422. doi:10.1111/j.1476-5381.2010.01176.x
  • Klumpers LE, Thacker DL. A brief background on cannabis: from plant to medical indications. J AOAC Int. 2019;102(2):412–420. doi:10.5740/jaoacint.18-0208
  • Taylor BN, Mueller M, Sauls RS. Cannabinoid Antiemetic Therapy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
  • Schulz KF, Altman DG, Moher D. CONSORT Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials. PLoS Med. 2010;7(3):e1000251.
  • Hsieh RK, Chan A, Kim HK, et al. Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries. Support Care Cancer. 2015;23(1):263–272. doi:10.1007/s00520-014-2373-2
  • Grimison P, Mersiades A, Kirby A, et al. Oral THC: CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, Phase II crossover trial. Ann Oncol. 2020;31(11):1553–1560. doi:10.1016/j.annonc.2020.07.020
  • Duran M, Pérez E, Abanades S, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol. 2010;70(5):656–663. doi:10.1111/j.1365-2125.2010.03743.x
  • Polito S, MacDonald T, Romanick M, et al. Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: a multicenter, retrospective review. Pediatr Blood Cancer. 2018;65(12):e27374. doi:10.1002/pbc.27374
  • Turcott JG, Del Rocío Guillen Núñez M, Flores-Estrada D, et al. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. Support Care Cancer. 2018;26(9):3029–3038. doi:10.1007/s00520-018-4154-9
  • Hanifa M, Wulandari R, Zulfin UM, Nugroho EP, Haryanti S, Meiyanto E. Different cytotoxic effects of vetiver oil on three types of cancer cells, mainly targeting CNR2 on TNBC. Asian Pac J Cancer Prev. 2022;23(1):241–251. doi:10.31557/APJCP.2022.23.1.241
  • Marzęda P, Wróblewska-łuczka P, Drozd M, Florek-łuszczki M, Załuska-Ogryzek K, Łuszczki JJ. Cannabidiol interacts antagonistically with cisplatin and additively with mitoxantrone in various melanoma cell lines-an isobolographic analysis. Int J Mol Sci. 2022;23(12):6752. doi:10.3390/ijms23126752
  • Alsherbiny MA, Li CG. Medicinal cannabis-potential drug interactions. Medicines. 2018;6(1):3. doi:10.3390/medicines6010003